Agios Pharmaceuticals Touts 2026 Growth Plan at JPM: Acvezmi Launch, SCD Data, Expense Discipline

Agios Pharmaceuticals (NASDAQ:AGIO) used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to outline its ...

Thalassemia Breakthrough: First-Ever Oral Drug Approved | Check Price

USFDA has cleared the world’s first oral therapy for the condition, a development that health experts say could transform ...

Agios Pharma Sets 2026 Strategic Priorities After AQVESME Approval

Detailed price information for Agios Pharmaceuticals (AGIO-Q) from The Globe and Mail including charting and trades.

Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...

First-ever oral pill Mitapivat likely to transform thalassaemia management: Experts

BHUBANESWAR: The New Year seems to have ushered in a major breakthrough for thalassaemia patients with the US Food and Drug ...
BioSpace

JPM26 Day 2: Companies Lay Out Near-Term Revenue, Longer-Term Business Goals

Biopharma companies—including AstraZeneca, BioNTech and Agios—peered farther into the future on the second day of JPM, ...

First Oral Pill For Adults With Thalassemia Anaemia Gets Approval, Experts Hail It As Game Changer

The US Food and Drug Administrations (FDA) approval of the first-ever oral pill for anaemia in adults with thalassemia marks ...
Medindia

FDA Approves Mitapivat- First Oral Treatment for Anemia in Thalassemia

Mitapivat is the first FDA-approved oral therapy for anaemia in all forms of thalassemia Reduced transfusion dependence may ...
Medindia

FDA Approves First Oral Drug for Thalassemia Anemia

FDA approves Mitapivat, the first oral treatment for thalassemia anemia, helping reduce transfusion needs and raise ...

Agios Pharma shares jump as U.S. FDA expands approval for blood disorder drug

Agios Pharma's shares soar 16% after FDA expands approval for its blood disorder drug, Aqvesme, set for late next month.
India Today on MSN

US approves first pill for thalassemia anemia: What this means for India

The US FDA has approved mitapivat, the first oral medicine for treating anemia caused by thalassemia. This approval marks a significant breakthrough offering hope to patients reliant on lifelong blood ...